In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Cymbalta (2004), and its antipsychotic medication Zyprexa (1996). Its primary revenue drivers are the diabetes ...

Zyprexa in 1996 for schizophrenia, and Cymbalta in 2004 for depression and anxiety. In the field of diabetes care, Lilly’s Humalog and Trulicity have been major revenue drivers. Eli Lilly and ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Paul spent 17 years at Eli Lilly, where he held roles including ... At Lilly, Paul helped develop the company’s mental health blockbusters, Zyprexa and Cymbalta, and helped oversee development ...

Rounding out the top 10 were Procrit (Johnson & Johnson), ranked fourth with $3.3 billion in 2003 US sales, up 3.7% from 2002; Zyprexa (Eli Lilly), ranked fifth with $3.2 billion, up 6.6% ...

J Midwifery Womens Health. 2007;52(1):3-13. There are no epidemiologic exposure data reported specifically for women with bipolar disorder who take anticonvulsants during pregnancy. Most data ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 71 trades. If we consider the specifics of each ...